'Small' data, isolated populations, and new categories of rare diseases in Finland and Poland.

IF 1.5 4区 社会学 Q2 ANTHROPOLOGY
Małgorzata Rajtar
{"title":"'Small' data, isolated populations, and new categories of rare diseases in Finland and Poland.","authors":"Małgorzata Rajtar","doi":"10.1080/13648470.2022.2152633","DOIUrl":null,"url":null,"abstract":"<p><p>Health policy and academic discourses on rare diseases and people with rare conditions frequently employ terms such as 'low prevalence' and 'unique' to characterize the smallness of the population under consideration and to justify targeted action toward these patient groups. This paper draws from recent anthropological scholarship on smallness and data, ethnographic research in Finland and Poland, as well as document and media analysis to examine how data is utilized in the context of isolated populations that are considered sites of rare diseases in these two countries. Specifically, this paper juxtaposes the notion of Finnish Disease Heritage (FDH) with that of a 'Kashubian gene' in Poland. The concept of FDH was developed by Finnish researchers in the 1970s; it encompasses almost forty rare hereditary diseases that are significantly more prevalent in Finland than elsewhere globally. On the other hand, the notion of the 'Kashubian gene' was first utilized by the media and some members of the Polish medical community around 2008. Based on 'unstable' data gathered during genetic research, the term referred to the high prevalence of a rare metabolic disorder (Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) deficiency) among Kashubians, an ethnic minority that resides in Northern Poland's Pomerania region. Whereas FDH facilitated the production and branding of 'a unique Finnish genetic identity' (Tupasela 2016b, 61), the notion of the 'Kashubian gene' has engendered health policy interventions targeting members of this ethnic minority and has contributed to stigmatizing practices carried out against Kashubians.</p>","PeriodicalId":8240,"journal":{"name":"Anthropology & Medicine","volume":"30 1","pages":"1-16"},"PeriodicalIF":1.5000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anthropology & Medicine","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1080/13648470.2022.2152633","RegionNum":4,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANTHROPOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Health policy and academic discourses on rare diseases and people with rare conditions frequently employ terms such as 'low prevalence' and 'unique' to characterize the smallness of the population under consideration and to justify targeted action toward these patient groups. This paper draws from recent anthropological scholarship on smallness and data, ethnographic research in Finland and Poland, as well as document and media analysis to examine how data is utilized in the context of isolated populations that are considered sites of rare diseases in these two countries. Specifically, this paper juxtaposes the notion of Finnish Disease Heritage (FDH) with that of a 'Kashubian gene' in Poland. The concept of FDH was developed by Finnish researchers in the 1970s; it encompasses almost forty rare hereditary diseases that are significantly more prevalent in Finland than elsewhere globally. On the other hand, the notion of the 'Kashubian gene' was first utilized by the media and some members of the Polish medical community around 2008. Based on 'unstable' data gathered during genetic research, the term referred to the high prevalence of a rare metabolic disorder (Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) deficiency) among Kashubians, an ethnic minority that resides in Northern Poland's Pomerania region. Whereas FDH facilitated the production and branding of 'a unique Finnish genetic identity' (Tupasela 2016b, 61), the notion of the 'Kashubian gene' has engendered health policy interventions targeting members of this ethnic minority and has contributed to stigmatizing practices carried out against Kashubians.

芬兰和波兰的“小”数据、孤立人群和罕见疾病新类别。
关于罕见病和罕见病患者的卫生政策和学术论述经常使用诸如“患病率低”和“独特”等术语来说明所考虑的人口较少的特点,并为针对这些患者群体采取有针对性的行动提供理由。本文借鉴了最近关于小规模和数据的人类学研究,芬兰和波兰的民族志研究,以及文件和媒体分析,以检查如何在这两个国家被认为是罕见疾病地点的孤立人群的背景下利用数据。具体来说,本文将芬兰疾病遗传(FDH)的概念与波兰的“卡舒比基因”并置。外佣的概念是由芬兰研究人员在20世纪70年代提出的;它涵盖了近40种罕见的遗传性疾病,这些疾病在芬兰比全球其他地方普遍得多。另一方面,媒体和波兰医学界的一些成员在2008年左右首次使用了“卡舒比人基因”的概念。根据基因研究期间收集的“不稳定”数据,该术语指的是居住在波兰北部波美拉尼亚地区的少数民族卡舒比亚人中一种罕见的代谢紊乱(长链3-羟基酰基辅酶a脱氢酶(LCHAD)缺乏症)的高患病率。尽管外帮工促进了“芬兰独特基因身份”的产生和品牌推广(Tupasela 2016b, 61),但“卡舒比基因”的概念引发了针对这一少数民族成员的卫生政策干预,并助长了针对卡舒比人的污名化做法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.90
自引率
0.00%
发文量
13
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信